NCT Number: NCT00421876
GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
Cardiac rehabilitation programmes are a proven treatment for individuals with recent myocardial infarction, resulting in reduced morbidity and mortality compared to usual care. Unfortunately, following completion of a cardiac rehabilitation programme, risk factors and lifestyle behaviours may deteriorate. The GOSPEL study investigates the benefits of a programme of continued educational and behavioural intervention to achieve optimal long-term secondary prevention goals.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Ospedale San Donato, Arezzo, AR, Italy
About this study
Study partially sponsored by Società Prodotti Antibiotici
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Recent myocardial infarction (within 3 months after the index event)
- Standard rehabilitation program of 3-6 weeks performed
- Informed consent (obtained before any study specific procedure)
Exclusion criteria
- Age > 75 years
- Any condition that in the opinion of the investigator would jeopardize the evaluation of efficacy or be associated with poor adherence to the protocol;
- Presence of any non-cardiac disease (e.g. cancer) that is likely to significantly shorten life expectancy
Treatment and study plan
Primary outcomes
-
cardiovascular mortality
-
non fatal re-MI
-
angina requiring hospitalization
-
urgent revascularization procedures
-
hospitalization for heart failure
-
non fatal stroke
Sponsors and collaborators
Lead sponsor
Heart Care Foundation
Other
Registry information
Important dates
- Study start
- 2000
- Study completion
- 2005
- First posted
- Jan 15, 2007
- Registry last updated
- Feb 3, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Women's Health Initiative Strong and Healthy Study
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsCES1 Crossover Trial of Clopidogrel and Ticagrelor
NCT03161678
Cardiovascular Diseases, Embolism and Thrombosis
Lancaster, Pennsylvania, United States
View Trial DetailsMental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis
NCT04123197
Cardiovascular Diseases, Heart Diseases
Atlanta, Georgia, United States
View Trial DetailsImproving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
NCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details